Development Level

Tbio 2 | 10,625
Tchem 1 | 1,890

IMPC Term

immune system phenotype 1 | 17

Disease

Cancer 3 | 2,346
Multiple Sclerosis 3 | 498
atypical teratoid / rhabdoid tumor 3 | 4,369
glioblastoma 3 | 5,572
intraductal papillary-mucinous adenoma (IPMA) 3 | 2,956
ovarian cancer 3 | 8,484
Alzheimer's disease 2 | 644
Atherosclerosis 2 | 275
Cerebrovascular disease 2 | 231
Coronary artery disease 2 | 240
Hypersensitivity 2 | 63
Hypersensitivity reaction type II disease 2 | 235
Kidney disease 2 | 396
Myocardial Ischemia 2 | 169
Pneumonia 2 | 133
adult high grade glioma 2 | 2,148
invasive ductal carcinoma 2 | 2,950
lung adenocarcinoma 2 | 2,713
lung cancer 2 | 4,466
lung carcinoma 2 | 2,844
pilocytic astrocytoma 2 | 3,086
posterior fossa group A ependymoma 2 | 1,511
psoriasis 2 | 6,685
sonic hedgehog group medulloblastoma 2 | 1,482
tuberculosis 2 | 1,557
Allergic hypersensitivity disease 1 | 123
Arthritis 1 | 248
Atopic dermatitis 1 | 944
Brain Ischemia 1 | 87
Bronchial Hyperreactivity 1 | 13
Calcinosis 1 | 62
Cardiovascular Diseases 1 | 50
Carotid Artery Diseases 1 | 11
Collagen disease 1 | 25
Crohn Disease 1 | 97
Dementia 1 | 129
Dermatitis 1 | 107
Diabetes Mellitus, Experimental 1 | 106
Diabetic Nephropathy 1 | 37
Drug-Induced Liver Injury 1 | 118
Encephalitis 1 | 54
Endometrial Neoplasms 1 | 50
Eye disease 1 | 55
Fatty liver disease 1 | 84
Gaucher disease type 3 1 | 76
Glomerulonephritis 1 | 36
HIV Infections 1 | 100
Heart disease 1 | 279
Heart valve disease 1 | 24
Hepatic encephalopathy 1 | 25
Hepatitis, Autoimmune 1 | 17
Human immunodeficiency virus infectious disease 1 | 92
Hyperalgesia 1 | 71
Hyperglycemia 1 | 120
Hypertension 1 | 287
Hypertensive disease 1 | 193
Infarction, Middle Cerebral Artery 1 | 25
Inflammation 1 | 109
Inflammatory bowel disease 1 | 142
Influenza 1 | 142
Kidney Failure, Chronic 1 | 45
Lipid metabolism disorder 1 | 102
Liver Cirrhosis 1 | 101
Liver Cirrhosis, Experimental 1 | 108
Liver disease 1 | 219
Liver diseases 1 | 66
Lung Injury 1 | 20
Lung disease 1 | 132
MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO (finding) 1 | 12
Meningitis 1 | 46
Metabolic syndrome X 1 | 155
Myocardial Reperfusion Injury 1 | 34
Myositis 1 | 24
Neural Tube Defects 1 | 27
Pancreatitis 1 | 97
Peripheral Neuropathy 1 | 303
Peripheral vascular disease 1 | 90
Peritonitis 1 | 37
Pontocerebellar hypoplasia 1 | 29
Pulmonary Fibrosis 1 | 66
Pulmonary hypertension 1 | 52
Reperfusion Injury 1 | 84
Status Epilepticus 1 | 85
Thyroid Neoplasm 1 | 33
Toxic encephalopathy 1 | 131
Tuberculosis, Pulmonary 1 | 3
Ureteral disease 1 | 23
Vasculitis 1 | 64
Waldenstrons macroglobulinemia 1 | 765
adrenocortical adenoma 1 | 134
adrenocortical carcinoma 1 | 1,427
astrocytoma 1 | 1,493
autosomal dominant Emery-Dreifuss muscular dystrophy 1 | 499
breast carcinoma 1 | 1,614
cystic fibrosis 1 | 1,665
head and neck cancer 1 | 270
nasopharyngeal carcinoma 1 | 1,056
non-inflammatory breast cancer 1 | 208
systemic lupus erythematosus 1 | 156
urothelial carcinoma 1 | 318

Tissue

Blood and immune system 3 | 17,995
Cardiovascular System 3 | 17,958
Digestive Tract 3 | 18,473
Endocrine System 3 | 18,512
Female tissues 3 | 18,647
Liver and Pancreas 3 | 18,136
Male tissues 3 | 17,969
Nervous System 3 | 18,561
Respiratory system 3 | 17,484
Urinary Tract 3 | 18,444
Skin and soft tissues 2 | 18,115

Target Family

Non-IDG 3 | 11,971

Grant Application

5F31NS046216-02 3 | 3
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
C-C motif chemokine 2 CCL2 Tchem Non-IDG -3.79323 6604.2 1001
Putative peripheral benzodiazepine receptor-related protein TSPO Tbio Non-IDG -3.29377 2078.3 186
Fractalkine CX3CL1 Tbio Non-IDG -2.68603 588.6 422